Management of Metastatic Melanoma 2005
- 30 April 2006
- journal article
- review article
- Published by Elsevier BV in Surgical Oncology Clinics of North America
- Vol. 15 (2), 419-437
- https://doi.org/10.1016/j.soc.2005.12.002
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Increased incidence of melanoma in renal transplantation recipientsCancer, 2005
- αvβ5-Integrins mediate early steps of metastasis formationEuropean Journal of Cancer, 2005
- Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV MelanomaJournal of Clinical Oncology, 2005
- CNTO 95, a fully human monoclonal antibody that inhibits αv integrins, has antitumor and antiangiogenic activity in vivoInternational Journal of Cancer, 2004
- Temozolomide in Combination With Docetaxel in Patients With Advanced Melanoma: A Phase II Study of the Hellenic Cooperative Oncology GroupJournal of Clinical Oncology, 2002
- Paclitaxel and tamoxifenCancer, 2000
- Taxol and vinorelbine: a new active combination for disseminated malignant melanomaAnti-Cancer Drugs, 1996
- Final report of the french multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastasesCancer, 1990
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983
- DTIC, CCNU, bleomycin and vincristine (BOLD) in metastatic melanomaCancer, 1980